AEMD - エスロン・メディカル （Aethlon Medical Inc.）

Gainers Aditxt, Inc. (NASDAQ: ADTX ) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market broad-spectrum antiviral drug Avigan. Augmedix, Inc. (NASDAQ: AUGX ) shares rose 64% to $2.96 after the company announced a partnership with HCA Healthcare to accelerate the development of AI-enabled ambient documentation. Aethlon Medical, Inc. (NASDAQ: AEMD ) gained 64% to $0.69. CNS Pharmaceuticals, Inc. (NASDAQ: CNSP ) rose 53% to $2.72. Getaround, Inc. (NYSE: GETR ) surged 38% to $0.4955 after jumping over 40% on Wednesday. Getaround recently said it sees preliminary FY22 total revenues of $59 million to $60 million. United Insurance Holdings Corp. (NASDAQ: UIHC ) gained 30.9% to $2.16. United Insurance said unit entered memorandum with Florida Department of Financial Services, Division of Rehabilitation and Liquidation. ContraFect Corporation (NASDAQ: CFRX ) rose 23% to $2.17. Satixfy Communications Ltd. (NYSE: SATX ) climbed 21% to $1.05.

In the last trading session, 0.2 million Aethlon Medical Inc. (NASDAQ:AEMD) shares changed hands as the company’s beta touched 1.23. With the company’s per share price at $0.54 changed hands at -$0.02 or -2.94% during last session, the market valuation stood at $12.80M. AEMD’s last price was a discount, traded about -355.56% off its 52-week … Aethlon Medical Inc. (NASDAQ: AEMD) Stock Forecast For 2023: $9.00 Per Share On The Upside Read More »

Aethlon Medical, Inc. (NASDAQ:NASDAQ:AEMD) Q3 2023 Earnings Conference Call February 13, 2023 4:30 PM ETCompany ParticipantsJim Frakes - Chief Financial OfficerSteven LaRosa - Chief Medical…

Aethlon Medical press release (AEMD): Q3 GAAP EPS of -$0.12 misses by $0.04.As of December 31, 2022, Aethlon Medical had a cash balance of approximately $17.5 million.Aethlon did…

Aethlon Medical (NASDAQ: AEMD ) is set to give its latest quarterly earnings report on Monday, 2023-02-13. Here''s what investors need to know before the announcement. Analysts estimate that Aethlon Medical will report an earnings per share (EPS) of $-0.17. Aethlon Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com

Aethlon Medical, Inc. (NASDAQ:NASDAQ:AEMD) Q2 2022 Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Charles Fisher - Chief Executive Officer James Frakes -…

Aethlon Medical press release (AEMD): Q2 GAAP EPS of -$0.18.As of September 30, 2022, Aethlon Medical had a cash balance of approximately $19.6 million.

Aethlon Medical (AEMD) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close.The consensus EPS Estimate is -$0.21 (-5.0% Y/Y) and the consensus…

SAN DIEGO, Nov. 2, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second quarter ended September 30, 2022, at 4:15…

The following slide deck was published by Aethlon Medical, Inc.

Wall Street analysts expect that Aethlon Medical, Inc. (NASDAQ:AEMD) will announce $260,000.00 in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Aethlon Medicals earnings. The highest sales estimate is $400,000.00 and the lowest is $110,000.00. Aethlon Medical reported sales of $630,000.00 in the same quarter last year, which []

Geode Capital Management LLC boosted its stake in Aethlon Medical, Inc. (NASDAQ:AEMD) by 54.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 103,121 shares of the medical equipment providers stock after purchasing an additional 36,368 shares during the period. Geode Capital Management LLC owned about 0.67% of []

Equities analysts forecast that Aethlon Medical, Inc. (NASDAQ:AEMD) will post earnings of ($0.13) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Aethlon Medicals earnings. Aethlon Medical posted earnings of ($0.20) per share in the same quarter last year, which indicates a positive year over year []

Wall Street analysts expect that Aethlon Medical, Inc. (NASDAQ:AEMD) will post ($0.18) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Aethlon Medicals earnings. The lowest EPS estimate is ($0.22) and the highest is ($0.13). Aethlon Medical posted earnings per share of ($0.20) in the same quarter []

Aethlon Medical (NASDAQ:AEMD) released its quarterly earnings data on Tuesday. The medical equipment provider reported ($0.13) EPS for the quarter, beating analysts consensus estimates of ($0.15) by $0.02, MarketWatch Earnings reports. During the same period in the prior year, the company posted ($0.15) earnings per share. Shares of Aethlon Medical stock traded up $0.07 during []